Healthwell Acquisition Corp. I announced today that it has postponed until further announcement the date of the special meeting of the Company’s stockholders to approve its proposed business.
Healthwell Acquisition Corp. I announced today that it has postponed the date of the special meeting of the Company’s stockholders to approve its proposed business combination with Starton.
Form 425 Healthwell Acquisition Filed by: Healthwell Acquisition Corp I streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J. (BUSINESS WIRE) Starton Therapeutics Inc. (“Starton” or “the Company”.
FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myelomaTreatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with STAR-LLDPARAMUS, N.J. (BUSINESS WIRE) Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical s.